Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes

被引:268
|
作者
de Bie, P.
Muller, P.
Wijmenga, C.
Klomp, L. W. J.
机构
[1] Univ Med Ctr, Lab Metab & Endocrine Dis, NL-3584 EA Utrecht, Netherlands
[2] Univ Med Ctr, DBG, Dept Med Genet, Complex Genet Sect, NL-3584 EA Utrecht, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands
关键词
D O I
10.1136/jmg.2007.052746
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The trace metal copper is essential for a variety of biological processes, but extremely toxic when present in excessive amounts. Therefore, concentrations of this metal in the body are kept under tight control. Central regulators of cellular copper metabolism are the copper-transporting P-type ATPases ATP7A and ATP7B. Mutations in ATP7A or ATP7B disrupt the homeostatic copper balance, resulting in copper deficiency ( Menkes disease) or copper overload ( Wilson disease), respectively. ATP7A and ATP7B exert their functions in copper transport through a variety of interdependent mechanisms and regulatory events, including their catalytic ATPase activity, copper-induced trafficking, post-translational modifications and protein - protein interactions. This paper reviews the extensive efforts that have been undertaken over the past few years to dissect and characterise these mechanisms, and how these are affected in Menkes and Wilson disease. As both disorders are characterised by an extensive clinical heterogeneity, we will discus how the underlying genetic defects correlate with the molecular functions of ATP7A and ATP7B and with the clinical expression of these disorders.
引用
收藏
页码:673 / 688
页数:16
相关论文
共 50 条
  • [41] Molecular pathogenesis of Parkinson's disease
    Gandhi, S
    Wood, NW
    HUMAN MOLECULAR GENETICS, 2005, 14 : 2749 - 2755
  • [42] Molecular pathogenesis of anemia of chronic disease
    Ganz, T
    PEDIATRIC BLOOD & CANCER, 2006, 46 (05) : 554 - 557
  • [43] Molecular Genetics and Pathogenesis of Parkinson Disease
    Saiki, Shinji
    Hattori, Nobutaka
    NEUROLOGICAL SURGERY, 2009, 37 (06): : 531 - 541
  • [44] Molecular Pathogenesis in Huntington's Disease
    Illarioshkin, S. N.
    Klyushnikov, S. A.
    Vigont, V. A.
    Seliverstov, Yu. A.
    Kaznacheyeva, E. V.
    BIOCHEMISTRY-MOSCOW, 2018, 83 (09) : 1030 - 1039
  • [45] Mechanisms of disease - Molecular pathogenesis of cholestasis
    Trauner, M
    Meier, PJ
    Boyer, JL
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (17): : 1217 - 1227
  • [46] Molecular Pathogenesis in Huntington’s Disease
    S. N. Illarioshkin
    S. A. Klyushnikov
    V. A. Vigont
    Yu. A. Seliverstov
    E. V. Kaznacheyeva
    Biochemistry (Moscow), 2018, 83 : 1030 - 1039
  • [47] Molecular pathogenesis of Crohn's disease
    Kustosz, Pawel
    Durlik, Marek
    PRZEGLAD GASTROENTEROLOGICZNY, 2013, 8 (01): : 21 - 26
  • [48] Molecular mechanism of copper transport in Wilson disease
    Fatemi, N
    Sarkar, B
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2002, 110 : 695 - 698
  • [49] Biochemical and molecular characterisation of neurological Wilson disease
    Seo, Go Hun
    Kim, Yoon-Myung
    Oh, Seak Hee
    Chung, Sun Ju
    Choi, In Hee
    Kim, Gu-Hwan
    Yum, Mi-Sun
    Choi, Jin-Ho
    Kim, Kyung Mo
    Ko, Tae-Sung
    Lee, Beom Hee
    Yoo, Han-Wook
    JOURNAL OF MEDICAL GENETICS, 2018, 55 (09) : 587 - 593
  • [50] The importance of molecular diagnosis for Wilson disease.
    Cox, DW
    Prat, LM
    Walshe, JM
    Roberts, EA
    Bilodeau, M
    HEPATOLOGY, 2003, 38 (04) : 230A - 230A